Fuchs Charles S.
SEC insider (Form 3/4/5 filer). CIK 0001719576. President, R&D at Erasca, Inc. (ERAS) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN DIEGO, CA.
Companies Fuchs Charles S. has filed insider reports for
- Erasca, Inc. (ERAS): Officer, President, R&D
- CytomX Therapeutics, Inc. (CTMX): Director
Fuchs Charles S.
CIK: 0001719576
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
